| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/09/1997 | EP0782620A1 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 07/09/1997 | EP0782619A1 Novel pka-binding proteins and uses thereof |
| 07/09/1997 | EP0782617A1 gp130 LACKING THE TRANSMEMBRANE DOMAIN |
| 07/09/1997 | EP0782616A1 Therapeutic grade thrombin production and products |
| 07/09/1997 | EP0782615A1 Dna encoding human papillomavirus type 6a |
| 07/09/1997 | EP0782584A1 Il-1 receptor antagonists with enhanced inhibitory activity |
| 07/09/1997 | EP0782581A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
| 07/09/1997 | EP0782579A1 Dna photocleavage using texaphyrins |
| 07/09/1997 | EP0782456A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 07/09/1997 | EP0782454A1 Use of muramyl peptide compounds |
| 07/09/1997 | EP0782453A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 07/09/1997 | EP0663836B1 Treatment of autoimmune and inflammatory disorders |
| 07/09/1997 | EP0478775B1 Peptide derivatives |
| 07/09/1997 | CN1154144A Isolated, tyrosinase derived peptides and uses thereof |
| 07/09/1997 | CN1154117A Synthetic peptide analogs of lung surfactant protein SP-C |
| 07/09/1997 | CN1154116A Peptide |
| 07/09/1997 | CN1154115A Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
| 07/09/1997 | CN1154114A New thrombin inhibitors, their preparation and use |
| 07/09/1997 | CN1154068A Pharmaceutical compositions comprising a chimaeric TNF binding protein |
| 07/09/1997 | CN1153785A Cyclic vasoactive peptide analogs |
| 07/09/1997 | CN1153784A Biotin derivatives |
| 07/08/1997 | US5646301 Incorporation into peptides |
| 07/08/1997 | US5646276 Angiotensin converting enzyme and neutral endopeptidase inhibitors; cardiovascular disorders |
| 07/08/1997 | US5646272 Bile acid conjugates of proline hydroxylase inhibitors |
| 07/08/1997 | US5646265 Process for the preparation of 2'-O-alkyl purine phosphoramidites |
| 07/08/1997 | US5646262 Binds encapsidation sequence of messenger rna intermediate; genetic engineering |
| 07/08/1997 | US5646259 DNA encoding haemophilus adhesion proteins |
| 07/08/1997 | US5646255 Reaction product of protein, succinimide derivative and tetrapeptide sequence of valine-histidine-leucine-threonine |
| 07/08/1997 | US5646254 Treating inflammation in humans and animals |
| 07/08/1997 | US5646251 Alloreaction-associated antigen (ARAG): a novel member of the immunoglobulin gene superfamily |
| 07/08/1997 | US5646249 Genetic engineering |
| 07/08/1997 | US5646248 E-selection binding soluble lamp-1 polypeptide |
| 07/08/1997 | US5646246 Isolation and structural elucidation of the human cancer cell growth inhibitory cyclic peptides phakellistatin 4, 5, 6, 7, 8 and 9 |
| 07/08/1997 | US5646245 Process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides |
| 07/08/1997 | US5646242 Amidation of insulin or derivative with soluble, activated fatty acid ester; one step |
| 07/08/1997 | US5646185 Administering protein kinase c activator consisting of phorbol ester, diacylglycerol, or thapsigargin to hypoxic cells |
| 07/08/1997 | US5646177 Glutathione derivatives of anthracyclines |
| 07/08/1997 | US5646165 Methionine sulfone and S-substituted cysteine sulfone derivatives as enzyme inhibitors |
| 07/08/1997 | US5646156 Administering xanthine derivative as antiinflammatory agent or antiallergen |
| 07/08/1997 | US5646140 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| 07/08/1997 | US5646121 Pseudopeptides with antiviral activity |
| 07/08/1997 | US5646120 Oligo- and polyarginine and derivatives |
| 07/08/1997 | US5646119 D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents |
| 07/08/1997 | US5646118 Glutamine, fatty acid, insulin-like growth factors |
| 07/08/1997 | US5646117 Therapeutic agent for treating wounds using monocyte chemotactic and activating factor |
| 07/08/1997 | US5646116 Administering insulin-like growth factor i to a mammal |
| 07/08/1997 | US5646115 Diagnosing allergic dermatitis; desensitizing animals to flea bites |
| 07/08/1997 | US5646114 Anti-protozoan methods |
| 07/08/1997 | US5646113 Treatment of partial growth hormone insensitivity syndrome |
| 07/08/1997 | US5646111 Cyclic peptide antifungal Agents |
| 07/08/1997 | US5646110 Cyclic peptides |
| 07/08/1997 | US5646109 Convertible microemulsion formulations |
| 07/08/1997 | US5646042 C-myb targeted ribozymes |
| 07/08/1997 | US5646041 Monoclonal antibody to herpes simplex virus and cell line producing same |
| 07/08/1997 | US5646040 Mammalian tub gene |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | US5646031 SArMV and sCYMVI hairpin ribozymes |
| 07/08/1997 | US5646029 Genetically engineered replacement for products derived from plant gums such as guar and gum arabic |
| 07/08/1997 | US5646027 Process for the production of gelatinase catalytic domain protein |
| 07/08/1997 | US5646021 Finderons and methods of their preparation and use |
| 07/08/1997 | US5646014 Peptide, antibacterial agent, peptide gene, recombinant DNA and method for preparing the peptide |
| 07/08/1997 | US5646011 Overcoming resistance of tumor cells to chemotheraputic agents, gene expression |
| 07/08/1997 | US5646008 Vertebrate apoptosis gene: compositions and methods |
| 07/08/1997 | US5645999 Assays for compounds that modulate or alter cyclin E activity |
| 07/08/1997 | US5645998 Detection of immunocomplex formed by glutamic acid decarboxylase protein with autoantibodies |
| 07/08/1997 | US5645997 Assay and treatment for demyelinating diseases such as multiple sclerosis, related hybridomas and monoclonal antibodies |
| 07/08/1997 | US5645988 Methods of identifying drugs with selective effects against cancer cells |
| 07/08/1997 | US5645986 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 07/08/1997 | US5645851 Collagen |
| 07/08/1997 | US5645837 Drugs to inhibit rejection of organ rejection after grafting; bone marrow grafting |
| 07/08/1997 | US5645836 Toxin conjugated to monoclonal antibody, then crosslinked, reverse transcriptase inhibitor |
| 07/08/1997 | US5645835 Therapeutic antibody based fusion proteins |
| 07/08/1997 | US5645834 Method and product for treating failure of passive transfer and improving milk production in bovine species |
| 07/08/1997 | US5645833 Inhibitor resistant serine proteases |
| 07/08/1997 | US5645832 Use of lipases for producing drugs |
| 07/08/1997 | US5645829 Mesothelial cell gene therapy |
| 07/08/1997 | US5645820 Treatment of autoimmune diseases by aerosol administration of autoantigens |
| 07/08/1997 | US5645817 Granulocyte-binding antibody constructs, their preparation and use |
| 07/03/1997 | WO1997023640A1 Human chemotactic cytokine i |
| 07/03/1997 | WO1997023639A1 Process for producing biologically active fused proteins |
| 07/03/1997 | WO1997023637A1 Galactopyranosides and their use |
| 07/03/1997 | WO1997023629A1 A novel receptor-type tyrosine kinase and use thereof |
| 07/03/1997 | WO1997023628A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
| 07/03/1997 | WO1997023626A1 Helicobacter pylori oxidoreductase enzymes and their uses |
| 07/03/1997 | WO1997023625A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 07/03/1997 | WO1997023624A2 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/03/1997 | WO1997023622A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023620A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023619A1 Sequences coding for new bacteriocins |
| 07/03/1997 | WO1997023616A1 Polypeptides with interleukin 16 activity, process for the preparation and use thereof |
| 07/03/1997 | WO1997023614A1 Osteoprotegerin |
| 07/03/1997 | WO1997023612A2 Targeted compounds with cartilage formation-inducing and/or bone formation-inducing activity |
| 07/03/1997 | WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | WO1997023610A1 Dna sequences associated with fraxe mental retardation |
| 07/03/1997 | WO1997023603A1 Method of isolating and growing recombinant eb viruses |
| 07/03/1997 | WO1997023510A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 07/03/1997 | WO1997023508A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023505A1 Two component signal transducing system protein from staphylococcus aureus |
| 07/03/1997 | WO1997023504A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |